Novel Lupus Agent Succeeds in Phase II Trial

(MedPage Today) -- A phase II trial of a monoclonal antibody known as BIIB059, which inhibits the production of interferon type 1, showed efficacy among patients with active systemic lupus erythematosus (SLE), a researcher reported.
On the study...